RESUMO
X-linked hypophosphataemia (XLH) rickets is a rare disease frequently misdiagnosed and mismanaged. Despite having clinical guidelines that offers some therapeutic recommendations based on the clinical experience of experts, physicians still have questions about some important aspects of the diagnosis and treatment of XLH, such as when the disease should be suspected, who should be in charge of the diagnosis, what should be done once the disease is diagnosed, or what therapeutic options are currently available. The objective of this paper is to answer some of the more frequent questions related to the management of patients with XLH by a group of experts participating in a scientific conference on XLH held in Madrid.
Assuntos
Anticorpos Monoclonais/uso terapêutico , Tratamento Farmacológico/normas , Raquitismo Hipofosfatêmico Familiar/diagnóstico , Raquitismo Hipofosfatêmico Familiar/tratamento farmacológico , Guias de Prática Clínica como Assunto , Adolescente , Criança , Pré-Escolar , Cálculos da Dosagem de Medicamento , Feminino , Fator de Crescimento de Fibroblastos 23 , Humanos , MasculinoRESUMO
In the original article, there is an error in age related reference.